AMGN
Price
$265.44
Change
+$4.43 (+1.70%)
Updated
Oct 4, 6:59 PM EST
27 days until earnings call
JNJ
Price
$155.46
Change
+$0.10 (+0.06%)
Updated
Oct 4, 6:59 PM EST
13 days until earnings call

Analysis and predictions AMGN vs JNJ

Header iconAMGN vs JNJ Comparison
Open Charts AMGN vs JNJBanner chart's image
Amgen
Price$265.44
Change+$4.43 (+1.70%)
Volume$1.37M
CapitalizationN/A
Johnson & Johnson
Price$155.46
Change+$0.10 (+0.06%)
Volume$1.32M
CapitalizationN/A
View a ticker or compare two or three
AMGN vs JNJ Comparison Chart

Loading...

Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
VS
AMGN vs. JNJ commentary
Oct 05, 2023

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AMGN is a StrongSell and JNJ is a StrongSell.

COMPARISON
Comparison
Oct 05, 2023
Stock price -- (AMGN: $261.04 vs. JNJ: $155.34)
Brand notoriety: AMGN and JNJ are both notable
Both companies represent the Pharmaceuticals: Major industry
Current volume relative to the 65-day Moving Average: AMGN: 100% vs. JNJ: 21%
Market capitalization -- AMGN: $142.45B vs. JNJ: $374.06B
AMGN [@Pharmaceuticals: Major] is valued at $142.45B. JNJ’s [@Pharmaceuticals: Major] market capitalization is $374.06B. The market cap for tickers in the [@Pharmaceuticals: Major] industry ranges from $511B to $0. The average market capitalization across the [@Pharmaceuticals: Major] industry is $79.5B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AMGN’s FA Score shows that 4 FA rating(s) are green whileJNJ’s FA Score has 3 green FA rating(s).

  • AMGN’s FA Score: 4 green, 1 red.
  • JNJ’s FA Score: 3 green, 2 red.
According to our system of comparison, AMGN is a better buy in the long-term than JNJ.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AMGN’s TA Score shows that 2 TA indicator(s) are bullish while JNJ’s TA Score has 4 bullish TA indicator(s).

  • AMGN’s TA Score: 2 bullish, 7 bearish.
  • JNJ’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, JNJ is a better buy in the short-term than AMGN.

Price Growth

AMGN (@Pharmaceuticals: Major) experienced а -2.97% price change this week, while JNJ (@Pharmaceuticals: Major) price change was -2.31% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was -0.60%. For the same industry, the average monthly price growth was -4.73%, and the average quarterly price growth was -5.21%.

Reported Earning Dates

AMGN is expected to report earnings on Oct 31, 2023.

JNJ is expected to report earnings on Oct 17, 2023.

Industries' Descriptions

@Pharmaceuticals: Major (-0.60% weekly)

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

SUMMARIES
A.I.dvisor published
a Summary for AMGN with price predictions.
OPEN
A.I.dvisor published
a Summary for JNJ with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
JNJ($374B) has a higher market cap than AMGN($142B). JNJ has higher P/E ratio than AMGN: JNJ (31.45) vs AMGN (17.95). AMGN YTD gains are higher at: 2.033 vs. JNJ (-10.115). JNJ has higher annual earnings (EBITDA): 24.1B vs. AMGN (14.8B). AMGN has more cash in the bank: 34.2B vs. JNJ (28.5B). JNJ has less debt than AMGN: JNJ (45.6B) vs AMGN (61.5B). JNJ has higher revenues than AMGN: JNJ (97.8B) vs AMGN (26.6B).
AMGNJNJAMGN / JNJ
Capitalization142B374B38%
EBITDA14.8B24.1B61%
Gain YTD2.033-10.115-20%
P/E Ratio17.9531.4557%
Revenue26.6B97.8B27%
Total Cash34.2B28.5B120%
Total Debt61.5B45.6B135%
FUNDAMENTALS RATINGS
AMGN vs JNJ: Fundamental Ratings
AMGN
JNJ
OUTLOOK RATING
1..100
6668
VALUATION
overvalued / fair valued / undervalued
1..100
12
Undervalued
20
Undervalued
PROFIT vs RISK RATING
1..100
1625
SMR RATING
1..100
1153
PRICE GROWTH RATING
1..100
1856
P/E GROWTH RATING
1..100
6527
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

AMGN's Valuation (12) in the Biotechnology industry is in the same range as JNJ (20) in the Pharmaceuticals Major industry. This means that AMGN’s stock grew similarly to JNJ’s over the last 12 months.

AMGN's Profit vs Risk Rating (16) in the Biotechnology industry is in the same range as JNJ (25) in the Pharmaceuticals Major industry. This means that AMGN’s stock grew similarly to JNJ’s over the last 12 months.

AMGN's SMR Rating (11) in the Biotechnology industry is somewhat better than the same rating for JNJ (53) in the Pharmaceuticals Major industry. This means that AMGN’s stock grew somewhat faster than JNJ’s over the last 12 months.

AMGN's Price Growth Rating (18) in the Biotechnology industry is somewhat better than the same rating for JNJ (56) in the Pharmaceuticals Major industry. This means that AMGN’s stock grew somewhat faster than JNJ’s over the last 12 months.

JNJ's P/E Growth Rating (27) in the Pharmaceuticals Major industry is somewhat better than the same rating for AMGN (65) in the Biotechnology industry. This means that JNJ’s stock grew somewhat faster than AMGN’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AMGNJNJ
RSI
ODDS (%)
Bearish Trend 2 days ago
71%
Bullish Trend 2 days ago
58%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
57%
Bullish Trend 2 days ago
51%
Momentum
ODDS (%)
Bearish Trend 2 days ago
64%
Bearish Trend 2 days ago
41%
MACD
ODDS (%)
Bearish Trend 2 days ago
57%
Bearish Trend 2 days ago
39%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
57%
Bearish Trend 2 days ago
41%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
49%
Bearish Trend 2 days ago
37%
Advances
ODDS (%)
Bullish Trend 15 days ago
53%
Bullish Trend 22 days ago
42%
Declines
ODDS (%)
Bearish Trend 2 days ago
53%
Bearish Trend 3 days ago
42%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
58%
Bullish Trend 2 days ago
59%
Aroon
ODDS (%)
Bearish Trend 2 days ago
45%
Bearish Trend 2 days ago
34%
View a ticker or compare two or three
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CDRE26.540.13
+0.49%
Cadre Holdings
NGG57.55-0.66
-1.13%
National Grid PLC
GFAI4.31-0.08
-1.82%
Guardforce AI Co Limited
VC131.60-4.60
-3.38%
Visteon Corp
OPAD7.80-0.48
-5.80%
Offerpad Solutions